142 related articles for article (PubMed ID: 33957960)
61. Mild haemostatic problems associated with congenital heterozygous alpha 2-antiplasmin deficiency.
Leebeek FW; Stibbe J; Knot EA; Kluft C; Gomes MJ; Beudeker M
Thromb Haemost; 1988 Feb; 59(1):96-100. PubMed ID: 3363537
[TBL] [Abstract][Full Text] [Related]
62. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction.
Matsuno H; Kozawa O; Yoshimi N; Akamatsu S; Hara A; Mori H; Okada K; Ueshima S; Matsuo O; Uematsu T
Blood; 2002 Oct; 100(7):2487-93. PubMed ID: 12239160
[TBL] [Abstract][Full Text] [Related]
63. Abnormal fibrinolysis recognized by thromboelastography in a case of severe bleeding with normal coagulation and platelet function, leads to detection of a novel SERPINF2 variant causing severe alpha-2-antiplasmin deficiency.
Egan G; Pluthero FG; Bouskill V; Hilliard P; Drury LJ; Carcao MD; Kahr WHA
Br J Haematol; 2019 Sep; 186(6):e198-e201. PubMed ID: 31282989
[No Abstract] [Full Text] [Related]
64. Physiological role of alpha 2-plasmin inhibitor in rats.
Kumada T; Abiko Y
Thromb Res; 1984 Oct; 36(2):153-63. PubMed ID: 6506034
[TBL] [Abstract][Full Text] [Related]
65. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
Angles-Cano E; Rouy D; Lijnen HR
Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
[TBL] [Abstract][Full Text] [Related]
66. Characterization and targeting of the murine alpha2-antiplasmin gene.
Okada K; Lijnen HR; Dewerchin M; Belayew A; Matsuo O; Collen D; Bernaerts R
Thromb Haemost; 1997 Sep; 78(3):1104-10. PubMed ID: 9308761
[TBL] [Abstract][Full Text] [Related]
67. Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis.
Goldman S; Frączek P; Szklanny K; Papuga-Szela E; Stanisz A; Undas A
Thromb Haemost; 2018 Apr; 118(4):654-663. PubMed ID: 29618152
[TBL] [Abstract][Full Text] [Related]
68. TEG Lysis Shutdown Represents Coagulopathy in Bleeding Trauma Patients: Analysis of the PROPPR Cohort.
Cardenas JC; Wade CE; Cotton BA; George MJ; Holcomb JB; Schreiber MA; White NJ;
Shock; 2019 Mar; 51(3):273-283. PubMed ID: 29664836
[TBL] [Abstract][Full Text] [Related]
69. Clinical significance of accelerated fibrinolysis in liver disease.
Francis RB; Feinstein DI
Haemostasis; 1984; 14(6):460-5. PubMed ID: 6534818
[TBL] [Abstract][Full Text] [Related]
70. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
[TBL] [Abstract][Full Text] [Related]
71. Lack of both α2-antiplasmin and plasminogen activator inhibitor type-1 induces high IgE production.
Okada K; Ueshima S; Kawao N; Yano M; Tamura Y; Tanaka M; Sakamoto A; Hatano M; Arima M; Miyata S; Nagai N; Tokuhisa T; Matsuo O
Life Sci; 2013 Jul; 93(2-3):89-95. PubMed ID: 23770230
[TBL] [Abstract][Full Text] [Related]
72. The influence of coronary angiography and angioplasty on parameters of hemostasis and fibrinolysis.
Six AJ; Tjon RM; Buys EM; Haas F; Hollander-van Zalk A; Haverkate F
Thromb Haemost; 1990 Aug; 64(1):113-6. PubMed ID: 2148844
[TBL] [Abstract][Full Text] [Related]
73. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
[TBL] [Abstract][Full Text] [Related]
74. Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever).
Lee M; Kim BK; Kim S; Park S; Han JS; Kim ST; Lee JS
Rev Infect Dis; 1989; 11 Suppl 4():S877-83. PubMed ID: 2568677
[TBL] [Abstract][Full Text] [Related]
75. [A homozygous quantitative defect of alpha 2-antiplasmin in a family from central Slovakia].
Zarnovicanova M; Mocikova K
Bratisl Lek Listy; 2000; 101(1):28-30. PubMed ID: 10824409
[TBL] [Abstract][Full Text] [Related]
76. A novel mutation of alpha2-plasmin inhibitor gene causes an inherited deficiency and a bleeding tendency.
Maino A; Garagiola I; Artoni A; Al-Humood S; Peyvandi F
Haemophilia; 2008 Jan; 14(1):166. PubMed ID: 17961166
[No Abstract] [Full Text] [Related]
77. Interaction of glycated and acetylated human α2-antiplasmin with fibrin clots.
Bryk AH; Satała D; Natorska J; Rąpała-Kozik M; Undas A
Blood Coagul Fibrinolysis; 2020 Sep; 31(6):393-396. PubMed ID: 32815915
[TBL] [Abstract][Full Text] [Related]
78. Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin-alpha 2-plasmin inhibitor complex and von Willebrand factor fragment in plasma.
Takahashi H; Koike T; Yoshida N; Kitahara O; Hanano M; Shibata A; Aoki N
Am J Hematol; 1986 Oct; 23(2):153-66. PubMed ID: 2944378
[TBL] [Abstract][Full Text] [Related]
79. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
[TBL] [Abstract][Full Text] [Related]
80. PAI-1 and α2-AP in patients with morbid obesity.
Michalska M; Iwan-Ziętek I; Gniłka W; Dąbrowiecki S; Góralczyk B; Góralczyk K; Drela E; Rość D
Adv Clin Exp Med; 2013; 22(6):801-7. PubMed ID: 24431308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
